Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation von Litton, Jennifer K, Rugo, Hope S, Ettl, Johannes, Hurvitz, Sara A, Gonçalves, Anthony, Lee, Kyung-Hun, Fehrenbacher, Louis, Yerushalmi, Rinat, Mina, Lida A, Martin, Miguel, Roché, Henri, Im, Young-Hyuck, Quek, Ruben G.W, Markova, Denka, Tudor, Iulia C, Hannah, Alison L, Eiermann, Wolfgang, Blum, Joanne L

Volltext

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study von Cortes, Javier, MD, O'Shaughnessy, Joyce, MD, Loesch, David, MD, Blum, Joanne L, MD, Vahdat, Linda T, MD, Petrakova, Katarina, MD, Chollet, Philippe, MD, Manikas, Alexey, MD, Diéras, Veronique, MD, Delozier, Thierry, MD, Vladimirov, Vladimir, MD, Cardoso, Fatima, MD, Koh, Han, MD, Bougnoux, Philippe, MD, Dutcus, Corina E, MD, Seegobin, Seth, MSc, Mir, Denis, MSc, Meneses, Nicole, MSHS, Wanders, Jantien, MD, Twelves, Chris, Prof

Volltext

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology) von Blum, Joanne L, Flynn, Patrick J, Yothers, Greg, Asmar, Lina, Geyer, Jr, Charles E, Jacobs, Samuel A, Robert, Nicholas J, Hopkins, Judith O, O'Shaughnessy, Joyce A, Dang, Chau T, Gómez, Henry Leonidas, Fehrenbacher, Louis, Vukelja, Svetislava J, Lyss, Alan P, Paul, Devchand, Brufsky, Adam M, Jeong, Jong-Hyeon, Colangelo, Linda H, Swain, Sandra M, Mamounas, Eleftherios P, Jones, Stephen E, Wolmark, Norman

Volltext

On grief, ghosts, and gallantry von Blum, Joanne L.

Volltext

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer von LIN, Nancy U, DIERAS, Véronique, LOIBL, Sibylle, GORI, Stefania, WARDLEY, Andrew, YARDLEY, Denise, BRUFSKY, Adam, BLUM, Joanne L, RUBIN, Stephen D, DHARAN, Bernie, STEPLEWSKI, Klaudia, ZEMBRYKI, Denise, PAUL, Devchand, OLIVA, Cristina, ROYCHOWDHURY, Debasish, PAOLETTI, Paolo, WINER, Eric P, LOSSIGNOL, Dominique, CHRISTODOULOU, Christos, STEMMLER, Hans-Joachim, ROCHE, Henri, LIU, Minetta C, GREIL, Richard, CIRUELOS, Eva

Volltext

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial von Hurvitz, Sara A., Gonçalves, Anthony, Rugo, Hope S., Lee, Kyung‐Hun, Fehrenbacher, Louis, Mina, Lida A., Diab, Sami, Blum, Joanne L., Chakrabarti, Jayeta, Elmeliegy, Mohamed, DeAnnuntis, Liza, Gauthier, Eric, Czibere, Akos, Tudor, Iulia Cristina, Quek, Ruben G.W., Litton, Jennifer K., Ettl, Johannes

Volltext

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality von Domchek, Susan M, Friebel, Tara M, Singer, Christian F, Evans, D. Gareth, Lynch, Henry T, Isaacs, Claudine, Garber, Judy E, Neuhausen, Susan L, Matloff, Ellen, Eeles, Rosalind, Pichert, Gabriella, Van t’veer, Laura, Tung, Nadine, Weitzel, Jeffrey N, Couch, Fergus J, Rubinstein, Wendy S, Ganz, Patricia A, Daly, Mary B, Olopade, Olufunmilayo I, Tomlinson, Gail, Schildkraut, Joellen, Blum, Joanne L, Rebbeck, Timothy R

Volltext

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 von JONES, Stephen, HOLMES, Frankie Ann, HYMAN, William J, RICHARDS, Donald A, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Wally G, ASMAR, Lina, MACKEY, Daniel, RIEDEL, Stefan, MUSS, Hyman, SAVIN, Michael A, O'SHAUGHNESSY, Joyce, BLUM, Joanne L, VUKELJA, Svetislava J, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert L, SANDBACH, John

Volltext

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study von KAUFF, Noah D, DOMCHEK, Susan M, NEUHAUSEN, Susan L, DALY, Mary B, MATLOFF, Ellen, BLUM, Joanne L, SABBATINI, Paul, BARAKAT, Richard R, HUDIS, Clifford, NORTON, Larry, OFFIT, Kenneth, REBBECK, Timothy R, FRIEBEL, Tara M, ROBSON, Mark E, LEE, Johanna, GARBER, Judy E, ISAACS, Claudine, EVANS, D. Gareth, LYNCH, Henry, EELES, Rosalind A

Volltext

Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial von Tripathy, Debu, Blum, Joanne L, Karuturi, Meghan S, McCune, Steven, Kurian, Sobha, Moezi, Mehdi, Anderson, Daniel, Gauthier, Eric, Zhang, Zhe, Montelongo, Monica Z, Wang, Yao, Rocque, Gabrielle B

Volltext

Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and... von Cortes, Javier, Vahdat, Linda, Blum, Joanne L, Twelves, Chris, Campone, Mario, Roché, Henri, Bachelot, Thomas, Awada, Ahmad, Paridaens, Robert, Goncalves, Anthony, Shuster, Dale E, Wanders, Jantien, Fang, Fang, Gurnani, Renuka, Richmond, Elaine, Cole, Patricia E, Ashworth, Simon, Allison, Mary Ann

Volltext

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study von Litton, Jennifer K, Beck, J Thaddeus, Jones, Jason M, Andersen, Jay, Blum, Joanne L, Mina, Lida A, Brig, Raymond, Danso, Michael, Yuan, Yuan, Abbattista, Antonello, Noonan, Kay, Niyazov, Alexander, Chakrabarti, Jayeta, Czibere, Akos, Symmans, William F, Telli, Melinda L

Volltext

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ von Ding, Lina, Su, Ying, Fassl, Anne, Hinohara, Kunihiko, Qiu, Xintao, Harper, Nicholas W., Huh, Sung Jin, Bloushtain-Qimron, Noga, Jovanović, Bojana, Ekram, Muhammad, Zi, Xiaoyuan, Hines, William C., Alečković, Maša, Gil del Alcazar, Carlos, Caulfield, Ryan J., Bonal, Dennis M., Nguyen, Quang-De, Merino, Vanessa F., Choudhury, Sibgat, Ethington, Gabrielle, Panos, Laura, Grant, Michael, Herlihy, William, Au, Alfred, Rosson, Gedge D., Argani, Pedram, Richardson, Andrea L., Dillon, Deborah, Allred, D. Craig, Babski, Kirsten, Kim, Elizabeth Min Hui, McDonnell, Charles H., Wagner, Jon, Rowberry, Ron, Bobolis, Kristie, Kleer, Celina G., Hwang, E. Shelley, Blum, Joanne L., Cristea, Simona, Sicinski, Piotr, Fan, Rong, Long, Henry W., Sukumar, Saraswati, Park, So Yeon, Garber, Judy E., Bissell, Mina, Yao, Jun, Polyak, Kornelia

Volltext

The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy von Pearson, Edward J., Nair, Anju, Daoud, Yahya, Blum, Joanne L.

Volltext

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer von JONES, Stephen E, SAVIN, Michael A, SANDBACH, John, HYMAN, William J, KHANDELWAL, Pankaj, NEGRON, Angel G, RICHARDS, Donald A, ANTHONY, Stephen P, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Walter G, ASMAR, Lina, HOLMES, Frankie Ann, O'SHAUGHNESSY, Joyce A, BLUM, Joanne L, VUKELJA, Svetislava, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert

Volltext

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane von VAHDAT, Linda T, PRUITT, Brian, SMITH, John, O'SHAUGHNESSY, Joyce, SHUSTER, Dale E, MENESES, Nicole L, CHANDRAWANSA, Kumari, FANG FANG, COLE, Patricia E, ASHWORTH, Simon, BLUM, Joanne L, FABIAN, Carol J, RIVERA, Ragene R, SMITH, David A, TAN-CHIU, Elizabeth, WRIGHT, Jonathan, TAN, Antoinette R, DACOSTA, NoshirA, CHUANG, Ellen

Volltext

Real-world quality-of-life of patients with HR+/HER2- advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS von Rocque, Gabrielle B, Blum, Joanne L, Ji, Yan, Pluard, Timothy, Migas, John, Lakhanpal, Shailendra, Jepsen, Erin, Gauthier, Eric, Wang, Yao, Montelongo, Monica Z, Cappelleri, Joseph C, Karuturi, Meghan S, Tripathy, Debu

Volltext

Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities von Craig, David W, O'Shaughnessy, Joyce A, Kiefer, Jeffrey A, Aldrich, Jessica, Sinari, Shripad, Moses, Tracy M, Wong, Shukmei, Dinh, Jennifer, Christoforides, Alexis, Blum, Joanne L, Aitelli, Cristi L, Osborne, Cynthia R, Izatt, Tyler, Kurdoglu, Ahmet, Baker, Angela, Koeman, Julie, Barbacioru, Catalin, Sakarya, Onur, De La Vega, Francisco M, Siddiqui, Asim, Hoang, Linh, Billings, Paul R, Salhia, Bodour, Tolcher, Anthony W, Trent, Jeffrey M, Mousses, Spyro, Von Hoff, Daniel, Carpten, John D

Volltext

Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer von Blum, Joanne L, Laird, A Douglas, Litton, Jennifer K, Rugo, Hope S, Ettl, Johannes, Hurvitz, Sara A, Martin, Miguel, Roché, Henri H, Lee, Kyung-Hun, Goodwin, Annabel, Chen, Ying, Lanzalone, Silvana, Chelliserry, Jijumon, Czibere, Akos, Hopkins, Julia F, Albacker, Lee A, Mina, Lida A

Volltext

Evolutionary pathways in BRCA1-associated breast tumors von Martins, Filipe C, De, Subhajyoti, Almendro, Vanessa, Gönen, Mithat, Park, So Yeon, Blum, Joanne L, Herlihy, William, Ethington, Gabrielle, Schnitt, Stuart J, Tung, Nadine, Garber, Judy E, Fetten, Katharina, Michor, Franziska, Polyak, Kornelia

Volltext